These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30457571)

  • 1. Generation and quality control of lipidomics data for the alzheimer's disease neuroimaging initiative cohort.
    Barupal DK; Fan S; Wancewicz B; Cajka T; Sa M; Showalter MR; Baillie R; Tenenbaum JD; Louie G; ; ; Kaddurah-Daouk R; Fiehn O
    Sci Data; 2018 Nov; 5():180263. PubMed ID: 30457571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort.
    Oka T; Matsuzawa Y; Tsuneyoshi M; Nakamura Y; Aoshima K; Tsugawa H;
    Sci Rep; 2024 Apr; 14(1):6797. PubMed ID: 38565541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical advances in analytical profiling of signature lipids: implications for severe non-communicable and neurodegenerative diseases.
    Sarkar S; Roy D; Chatterjee B; Ghosh R
    Metabolomics; 2024 Mar; 20(2):37. PubMed ID: 38459207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease.
    Huynh K; Lim WLF; Giles C; Jayawardana KS; Salim A; Mellett NA; Smith AAT; Olshansky G; Drew BG; Chatterjee P; Martins I; Laws SM; Bush AI; Rowe CC; Villemagne VL; Ames D; Masters CL; Arnold M; Nho K; Saykin AJ; Baillie R; Han X; Kaddurah-Daouk R; Martins RN; Meikle PJ
    Nat Commun; 2020 Nov; 11(1):5698. PubMed ID: 33173055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Sphingomyelins in Late-Onset Alzheimer's Disease.
    Fote G; Wu J; Mapstone M; Macciardi F; Fiandaca MS; Federoff HJ
    J Alzheimers Dis; 2021; 83(3):1161-1171. PubMed ID: 34397408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between plasma and PET beta-amyloid levels in individuals with subjective cognitive decline: the Fundació ACE Healthy Brain Initiative (FACEHBI).
    de Rojas I; Romero J; Rodríguez-Gomez O; Pesini P; Sanabria A; Pérez-Cordon A; Abdelnour C; Hernández I; Rosende-Roca M; Mauleón A; Vargas L; Alegret M; Espinosa A; Ortega G; Gil S; Guitart M; Gailhajanet A; Santos-Santos MA; Moreno-Grau S; Sotolongo-Grau O; Ruiz S; Montrreal L; Martín E; Pelejà E; Lomeña F; Campos F; Vivas A; Gómez-Chiari M; Tejero MA; Giménez J; Pérez-Grijalba V; Marquié GM; Monté-Rubio G; Valero S; Orellana A; Tárraga L; Sarasa M; Ruiz A; Boada M;
    Alzheimers Res Ther; 2018 Nov; 10(1):119. PubMed ID: 30497535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Soluble Triggering Receptor Expressed on Myeloid Cells 2 as a Biomarker for Incident Dementia: The Hisayama Study.
    Ohara T; Hata J; Tanaka M; Honda T; Yamakage H; Yoshida D; Inoue T; Hirakawa Y; Kusakabe T; Shibata M; Teraoka T; Kitazono T; Kanba S; Satoh-Asahara N; Ninomiya T
    Ann Neurol; 2019 Jan; 85(1):47-58. PubMed ID: 30485483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Functional Performance and Alzheimer's Disease Biomarkers in Individuals Without Dementia.
    Vassilaki M; Aakre JA; Kremers WK; Mielke MM; Geda YE; Machulda MM; Knopman DS; Coloma PM; Schauble B; Vemuri P; Lowe VJ; Jack CR; Petersen RC; Roberts RO
    J Am Geriatr Soc; 2018 Dec; 66(12):2274-2281. PubMed ID: 30462843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure Annotation of All Mass Spectra in Untargeted Metabolomics.
    Blaženović I; Kind T; Sa MR; Ji J; Vaniya A; Wancewicz B; Roberts BS; Torbašinović H; Lee T; Mehta SS; Showalter MR; Song H; Kwok J; Jahn D; Kim J; Fiehn O
    Anal Chem; 2019 Feb; 91(3):2155-2162. PubMed ID: 30608141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary lysophosphatidylcholine-EPA enriches both EPA and DHA in the brain: potential treatment for depression.
    Yalagala PCR; Sugasini D; Dasarathi S; Pahan K; Subbaiah PV
    J Lipid Res; 2019 Mar; 60(3):566-578. PubMed ID: 30530735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology.
    Barupal DK; Baillie R; Fan S; Saykin AJ; Meikle PJ; Arnold M; Nho K; Fiehn O; Kaddurah-Daouk R;
    Alzheimers Dement (Amst); 2019 Dec; 11():619-627. PubMed ID: 31517024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.
    St John-Williams L; Mahmoudiandehkordi S; Arnold M; Massaro T; Blach C; Kastenmüller G; Louie G; Kueider-Paisley A; Han X; Baillie R; Motsinger-Reif AA; Rotroff D; Nho K; Saykin AJ; Risacher SL; Koal T; Moseley MA; Tenenbaum JD; Thompson JW; Kaddurah-Daouk R; ;
    Sci Data; 2019 Oct; 6(1):212. PubMed ID: 31624257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Dietary Supplementation with EPA-enriched Phosphatidylcholine and Phosphatidylethanolamine on Glycerophospholipid Profile in Cerebral Cortex of SAMP8 Mice fed with High-fat Diet.
    Zhang C; Zhou MM; Zhang TT; Cong PX; Xu J; Xue CH; Yanagita T; Wei ZH; Wang YM
    J Oleo Sci; 2021 Feb; 70(2):275-287. PubMed ID: 33456004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
    Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
    Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent fasting protects against Alzheimer's disease in mice by altering metabolism through remodeling of the gut microbiota.
    Pan RY; Zhang J; Wang J; Wang Y; Li Z; Liao Y; Liao Y; Zhang C; Liu Z; Song L; Yu J; Yuan Z
    Nat Aging; 2022 Nov; 2(11):1024-1039. PubMed ID: 37118092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent fasting to slow down Alzheimer's disease.
    Nicolas S; Nolan YM
    Nat Aging; 2022 Nov; 2(11):982-983. PubMed ID: 37118091
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigating the causal association between branched-chain amino acids and Alzheimer's disease: A bidirectional Mendelian randomized study.
    Qian XH; Liu XL; Zhang B; Lin Y; Xu JH; Ding GY; Tang HD
    Front Nutr; 2023; 10():1103303. PubMed ID: 37063328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional contributions of D-serine to Alzheimer's disease pathology in male
    Ni X; Inoue R; Wu Y; Yoshida T; Yaku K; Nakagawa T; Saito T; Saido TC; Takao K; Mori H
    Front Aging Neurosci; 2023; 15():1211067. PubMed ID: 37455930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDSL.GOA: Gene Ontology Analysis for Interpreting Metabolomic datasets.
    Mahajan P; Fiehn O; Barupal D
    bioRxiv; 2024 Jan; ():. PubMed ID: 37034715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.